
Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Tech Development Disclosed: A Survey of \Usefulness and Configuration in Concentration\ Tech Item - 2
CDC's upcoming vote on hepatitis B vaccine could impact childhood immunization - 3
Iran executes two men who tried storming military facility during January protest crackdown - 4
In blow to Lula, Brazil Congress revives controversial environmental bill - 5
Ukraine: Russians abduct 50 Ukrainians from border village in Sumy
Pick Your Favored kind of books
UK forecast to face weaker growth and higher inflation from Iran war
Nature's Best: A Manual for Beautiful Train Rides
What is the Significant Tech Expertise to Master Today?
Public Parks in the USA
Ukraine proved this drone-killer works. Now, the West is giving it a shot.
Bolsonaro says hallucinatory effects of meds made him tamper with ankle tag
India’s delayed climate plan sets modest emission target
What to know about Jack Dorsey's new Vine revival, DiVine












